Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Public ClinicalTrials.gov record NCT00003821. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Study identification
- NCT ID
- NCT00003821
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- aminopterin Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 120 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 1997
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Sep 17, 2018
Started 1998
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Division of Gynecologic Oncology | St Louis | Missouri | 63110 | — |
| East Carolina University School of Medicine | Greenville | North Carolina | 27858-4354 | — |
| Gynecologic Oncologists of NE Ohio | Akron | Ohio | 44302 | — |
| Simmons Cancer Center - Dallas | Dallas | Texas | 75235-9154 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75246 | — |
| University of Wisconsin Comprehensive Cancer Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003821, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00003821 live on ClinicalTrials.gov.